Circulation: Heart Failure

Journal

Publication Venue For

  • Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study.  13:e006863. 2020
  • Inflammation and Circulating Natriuretic Peptide Levels 2020
  • Characteristics and healthcare utilization among veterans treated for heart failure with reduced ejection fraction who switched to sacubitril/valsartan.  12. 2019
  • Intra-aortic Balloon Pump As a Bridge to Heart Transplant after Non-ST-Segment-Elevation Myocardial Infarction in Palliated Hypoplastic Left Heart Syndrome.  12. 2019
  • Prevalence of American Heart Association Heart Failure Stages in Black and White Young and Middle-Aged Adults: The CARDIA Study.  12. 2019
  • IGFBP7 (Insulin-Like Growth Factor-Binding Protein-7) and Neprilysin Inhibition in Patients With Heart Failure.  11:e005133. 2018
  • Racial Differences in Characteristics and Outcomes of Patients With Heart Failure and Preserved Ejection Fraction in the Treatment of Preserved Cardiac Function Heart Failure Trial.  11:e004457. 2018
  • Predicting Risk in Patients Hospitalized for Acute Decompensated Heart Failure and Preserved Ejection Fraction: The Atherosclerosis Risk in Communities Study Heart Failure Community Surveillance.  10. 2017
  • Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.  10. 2017
  • Myocardial Upregulation of Cathepsin D by Ischemic Heart Disease Promotes Autophagic Flux and Protects Against Cardiac Remodeling and Heart Failure.  10. 2017
  • Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.  10. 2017
  • Activated T lymphocytes are essential drivers of pathological remodeling in ischemic heart failure.  10. 2017
  • Intracardiac Pressures Measured Using an Implantable Hemodynamic Monitor: Relationship to Mortality in Patients with Chronic Heart Failure.  10. 2017
  • Dying with a Left Ventricular Assist Device as Destination Therapy.  9. 2016
  • Association of weight and body composition on cardiac structure and function in the ARIC study (Atherosclerosis Risk in Communities).  9. 2016
  • Pulmonary Artery Pressure-Guided Heart Failure Management Reduces 30-Day Readmissions.  9. 2016
  • Heart failure and midrange ejection fraction.  9. 2016
  • Prognostic relevance of left atrial dysfunction in heart failure with preserved ejection fraction.  9. 2016
  • Clinical Characteristics and Outcomes of Intravenous Inotropic Therapy in Advanced Heart Failure.  8:880-886. 2015
  • Duration of Heart Failure Is an Important Predictor of Outcomes after Mechanical Circulatory Support.  8:953-959. 2015
  • Response to Letter Regarding Article, "cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk in the Community Study".  8:1010. 2015
  • Alcohol and Incident Heart Failure among Middle-Aged and Elderly Men: Cohort of Swedish Men.  8:422-427. 2015
  • Cardiac Structure and Function Across the Glycemic Spectrum in Elderly Men and Women Free of Prevalent Heart Disease: The Atherosclerosis Risk in the Community Study.  8:448-454. 2015
  • Central cardiac limit to aerobic capacity in patients with exertional pulmonary venous hypertension: Implications for heart failure with preserved ejection fraction.  8:278-285. 2015
  • Characteristics and outcomes of patients with advanced chronic systolic heart failure receiving care at the veterans affairs versus other hospitals insights from the Beta-blocker Evaluation of Survival Trial (BEST).  8:17-24. 2015
  • Derivation and high engraftment of patient-specific cardiomyocyte sheet using induced pluripotent stem cells generated from adult cardiac fibroblast.  8:156-166. 2015
  • Discharge hospice referral and lower 30-day all-cause readmission in medicare beneficiaries hospitalized for heart failure.  8:733-740. 2015
  • E/e′ ratio in patients with unexplained dyspnea lack of accuracy in estimating left ventricular filling pressure.  8:749-756. 2015
  • Effects of intracoronary infusion of escalating doses of cardiac stem cells in rats with acute myocardial infarction.  8:757-765. 2015
  • Heart Failure Management in Skilled Nursing Facilities: A Scientific Statement from the American Heart Association and the Heart Failure Society of America.  8:655-687. 2015
  • Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.  8:1052-1058. 2015
  • Prognostic Significance of Depression in Blacks with Heart Failure: Insights from Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training.  8:497-503. 2015
  • Risk of heart failure among postmenopausal women a secondary analysis of the randomized trial of Vitamin D plus calcium of the women's health initiative.  8:49-56. 2015
  • Risk of heart failure and death after prolonged smoking cessation: Role of amount and duration of prior smoking.  8:694-701. 2015
  • Transitions of care in heart failure: A scientific statement from the American heart association.  8:384-409. 2015
  • Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction.  7:935-944. 2014
  • Calcium channel blockers and outcomes in older patients with heart failure and preserved ejection fraction.  7:945-952. 2014
  • Cardiac structure and function and prognosis in heart failure with preserved ejection fraction.  7:740-751. 2014
  • Cardiac structure and function in heart failure with preserved ejection fraction: Baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial.  7:104-115. 2014
  • Elevation in high-sensitivity troponin t in heart failure and preserved ejection fraction and influence of treatment with the angiotensin receptor neprilysin inhibitor LCZ696.  7:953-959. 2014
  • Increased sarcolipin expression and adrenergic drive in humans with preserved left ventricular ejection fraction and chronic isolated mitral regurgitation.  7:194-202. 2014
  • Left atrial volume and the benefit of cardiac resynchronization therapy in the MADIT-CRT Trial.  7:154-160. 2014
  • Metabolomic analysis of pressure-overloaded and infarcted mouse hearts.  7:634-642. 2014
  • Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.  6:508-516. 2013
  • Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy.  6:435-442. 2013
  • Mediterranean and DASH diet scores and mortality in women with heart failure the women s health initiative.  6:1116-1123. 2013
  • Response to letter regarding article, habitual coffee consumption and risk of heart failure: A dose-response meta-analysis.  5. 2012
  • Anisotropic reinforcement of acute anteroapical infarcts improves pump function.  5:515-522. 2012
  • Habitual coffee consumption and risk of heart failure a dose-response meta-analysis.  5:401-405. 2012
  • Coffee consumption and incidence of heart failure in women.  4:414-418. 2011
  • Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.  4:433-440. 2011
  • Response to letter regarding article, "chocolate intake and incidence of heart failure: A population-based, prospective study of middle-aged and elderly women".  4. 2011
  • Chocolate intake and incidence of heart failure a population-based prospective study of middle-aged and elderly women.  3:612-616. 2010
  • Chronic ambulatory intracardiac pressures and future heart failure events.  3:580-587. 2010
  • Editorial: Can vitamin D supplementation improve physical function and quality of life in older patients with heart failure?.  3:183-184. 2010
  • Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease findings from propensity-matched studies.  3:253-260. 2010
  • Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure a propensity-matched study.  3:118-124. 2010
  • α1-adrenergic receptor subtypes in nonfailing and failing human myocardium.  2:654-663. 2009
  • Adiposity and incidence of heart failure hospitalization and mortality: A population-based prospective study.  2:202-208. 2009
  • Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial.  2:181-188. 2009
  • Mechanical circulatory support: registering a therapy in evolution..  1:200-205. 2008
  • Prognostic Awareness and Goals of Care Discussions Among Patients with Advanced Heart Failure
  • International Standard Serial Number (issn)

  • 1941-3289
  • Electronic International Standard Serial Number (eissn)

  • 1941-3297